Chronic Myeloid Leukemia with Variant Chromosomal Translocations: Results of Treatment with Imatinib Mesylate
Objective: To evaluate the efficacy of imatinib in chronic myeloid leukemia patients with variant translocations. Methods: Forty eight chronic myeloid leukemia patients carrying variant translocations and treated with imatinib at our institute were considered for the study. Survival and response rat...
Main Authors: | Rohan Bhise, Samit Purohit, Lokanatha D, Linu Jacob, Suresh TM, Govind Babu K, Suresh Babu, Lakshmaiah KC |
---|---|
Format: | Article |
Language: | English |
Published: |
Light House Polyclinic Mangalore
2013-01-01
|
Series: | Online Journal of Health & Allied Sciences |
Subjects: | |
Online Access: | http://www.ojhas.org/issue44/2012-4-5.html |
Similar Items
-
Imatinib Mesylate Treatment in Chronic Myeloid Leukemia
by: Demet Çekdemir, et al.
Published: (2020-03-01) -
Outcome of young adults with chronic myeloid leukemia treated with upfront imatinib: A single institutional experience
by: Govind K Babu, et al.
Published: (2015-01-01) -
OUR EXPERIENCE WITH TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Mojca Modic, et al.
Published: (2004-12-01) -
OUR EXPERIENCE IN TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Marjana Glaser, et al.
Published: (2004-04-01) -
Platelet Dysfunction in Patients with Chronic Myeloid Leukemia: Does Imatinib Mesylate Improve It?
by: Olga Meltem Akay, et al.
Published: (2016-05-01)